CCI vs EDIT
Crown Castle (CCI) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the CCI and EDIT stock pages for the full models.
Not investment advice.